Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis.
Olivares-Hernández A, Roldán-Ruiz J, Miramontes-González JP, Toribio-García I, García-Hernández JL, Posado-Domínguez L, Bellido-Hernández L, Cruz-Hernández JJ, Fonseca-Sánchez E, Del Barco-Morillo E.
Olivares-Hernández A, et al. Among authors: posado dominguez l.
Chin Clin Oncol. 2023 Dec;12(6):62. doi: 10.21037/cco-23-58.
Chin Clin Oncol. 2023.
PMID: 38195073
Free article.